General Information of DTT (ID: TT1UCIJ)

DTT Name C-X-C chemokine receptor type 3 (CXCR3) DTT Info
Gene Name CXCR3

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Discontinued Drug(s)
Preclinical Drug(s)
Investigative Drug(s)
1 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
T487 DMZTL7H Psoriatic disorder EA90 Discontinued in Phase 2 [1]
------------------------------------------------------------------------------------
2 Preclinical Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
dioscin DM5H2W9 Hepatic fibrosis DB93.0 Preclinical [2]
JT07 DMHBWOP Solid tumour/cancer 2A00-2F9Z Preclinical [3]
------------------------------------------------------------------------------------
4 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
hypoglaucin A DMJKIUX Discovery agent N.A. Investigative [2]
kallstroemin D DM7YAE0 Discovery agent N.A. Investigative [2]
NBI-74330 DMURC6X Discovery agent N.A. Investigative [1]
Sch-900875 DM346KA Inflammation 1A00-CA43.1 Investigative [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist. J Pharmacol Exp Ther. 2005 Jun;313(3):1263-71.
2 Discovery of structurally diverse natural product antagonists of chemokine receptor CXCR3. Mol Divers. 2005;9(1-3):123-9.
3 Clinical pipeline report, company report or official report of Jyant Technologies.
4 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 70).